Stay updated on SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial

Sign up to get notified when there's something new on the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision label updated: added 'Revision: v3.3.2' and removed 'Revision: v3.2.0'.
    Difference
    0.0%
    Check dated 2025-11-27T04:05:57.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Removed the government funding notice that warned about potential delays and unprocessed transactions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-19T21:50:04.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Observed changes are limited to UI updates and an updated last-updated timestamp; core study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-29T04:46:19.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    - Added a government funding notice and operating status information for NIH Clinical Center, plus a new version tag v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T16:07:27.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Page now shows that results have been submitted and updates the revision to v3.1.0, replacing the previous state (No Results Posted, revision v3.0.2).
    Difference
    0.2%
    Check dated 2025-09-29T10:00:31.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Page updated to revision v3.0.2; a Back to Top link was removed. No significant changes to core content, pricing, stock, or time-based information.
    Difference
    0.2%
    Check dated 2025-09-15T00:18:41.000Z thumbnail image

Stay in the know with updates to SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page.